241 related articles for article (PubMed ID: 18508079)
1. Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2.
Peabody DS; Manifold-Wheeler B; Medford A; Jordan SK; do Carmo Caldeira J; Chackerian B
J Mol Biol; 2008 Jun; 380(1):252-63. PubMed ID: 18508079
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7.
Caldeira Jdo C; Medford A; Kines RC; Lino CA; Schiller JT; Chackerian B; Peabody DS
Vaccine; 2010 Jun; 28(27):4384-93. PubMed ID: 20434554
[TBL] [Abstract][Full Text] [Related]
3. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.
Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B
PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502
[TBL] [Abstract][Full Text] [Related]
4. Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.
Chackerian B; Caldeira Jdo C; Peabody J; Peabody DS
J Mol Biol; 2011 Jun; 409(2):225-37. PubMed ID: 21501621
[TBL] [Abstract][Full Text] [Related]
5. Thermal stability of RNA phage virus-like particles displaying foreign peptides.
Caldeira JC; Peabody DS
J Nanobiotechnology; 2011 May; 9():22. PubMed ID: 21609437
[TBL] [Abstract][Full Text] [Related]
6. VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus.
Tumban E; Peabody J; Tyler M; Peabody DS; Chackerian B
PLoS One; 2012; 7(11):e49751. PubMed ID: 23185426
[TBL] [Abstract][Full Text] [Related]
7. A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.
Zhai L; Peabody J; Pang YS; Schiller J; Chackerian B; Tumban E
Antiviral Res; 2017 Nov; 147():116-123. PubMed ID: 28939477
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.
Ashley CE; Carnes EC; Phillips GK; Durfee PN; Buley MD; Lino CA; Padilla DP; Phillips B; Carter MB; Willman CL; Brinker CJ; Caldeira Jdo C; Chackerian B; Wharton W; Peabody DS
ACS Nano; 2011 Jul; 5(7):5729-45. PubMed ID: 21615170
[TBL] [Abstract][Full Text] [Related]
9. MS2 Virus-like Particles as a Versatile Peptide Presentation Platform: Insights into the Deterministic Abilities for Accommodating Heterologous Peptide Lengths.
Dang M; Wu LJ; Zhang SR; Zhu JR; Hu YZ; Yang CX; Zhang XY
ACS Synth Biol; 2023 Dec; 12(12):3704-3715. PubMed ID: 37946498
[TBL] [Abstract][Full Text] [Related]
10. Subunit fusion confers tolerance to peptide insertions in a virus coat protein.
Peabody DS
Arch Biochem Biophys; 1997 Nov; 347(1):85-92. PubMed ID: 9344468
[TBL] [Abstract][Full Text] [Related]
11. Display of single-chain variable fragments on bacteriophage MS2 virus-like particles.
Lino CA; Caldeira JC; Peabody DS
J Nanobiotechnology; 2017 Feb; 15(1):13. PubMed ID: 28193211
[TBL] [Abstract][Full Text] [Related]
12. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
Li J; Sun Y; Jia T; Zhang R; Zhang K; Wang L
Int J Cancer; 2014 Apr; 134(7):1683-94. PubMed ID: 24105486
[TBL] [Abstract][Full Text] [Related]
13. Dual Surface Modification of Genome-Free MS2 Capsids for Delivery Applications.
Aanei IL; Francis MB
Methods Mol Biol; 2018; 1776():629-642. PubMed ID: 29869270
[TBL] [Abstract][Full Text] [Related]
14. Selection and evaluation of single domain antibodies toward MS2 phage and coat protein.
Liu JL; Zabetakis D; Goldman ER; Anderson GP
Mol Immunol; 2013 Jan; 53(1-2):118-25. PubMed ID: 22898187
[TBL] [Abstract][Full Text] [Related]
15. Expression and immunogenicity of a liver stage malaria epitope presented as a foreign peptide on the surface of RNA-free MS2 bacteriophage capsids.
Heal KG; Hill HR; Stockley PG; Hollingdale MR; Taylor-Robinson AW
Vaccine; 1999 Sep; 18(3-4):251-8. PubMed ID: 10506649
[TBL] [Abstract][Full Text] [Related]
16. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.
Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B
Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490
[TBL] [Abstract][Full Text] [Related]
17. Homodimeric peptides displayed by the major coat protein of filamentous phage.
Zwick MB; Shen J; Scott JK
J Mol Biol; 2000 Jul; 300(2):307-20. PubMed ID: 10873467
[TBL] [Abstract][Full Text] [Related]
18. Engineering a Virus-like Particle to Display Peptide Insertions Using an Apparent Fitness Landscape.
Robinson SA; Hartman EC; Ikwuagwu BC; Francis MB; Tullman-Ercek D
Biomacromolecules; 2020 Oct; 21(10):4194-4204. PubMed ID: 32880435
[TBL] [Abstract][Full Text] [Related]
19. Analysis of phage MS2 coat protein mutants expressed from a reconstituted phagemid reveals that proline 78 is essential for viral infectivity.
Hill HR; Stonehouse NJ; Fonseca SA; Stockley PG
J Mol Biol; 1997 Feb; 266(1):1-7. PubMed ID: 9054964
[TBL] [Abstract][Full Text] [Related]
20. Engineering the PP7 Virus Capsid as a Peptide Display Platform.
Zhao L; Kopylov M; Potter CS; Carragher B; Finn MG
ACS Nano; 2019 Apr; 13(4):4443-4454. PubMed ID: 30912918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
